361 related articles for article (PubMed ID: 9165060)
41. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
[TBL] [Abstract][Full Text] [Related]
42. Functional studies of a glucagon receptor isolated from frog Rana tigrina rugulosa: implications on the molecular evolution of glucagon receptors in vertebrates.
Ngan ES; Chow LS; Tse DL; Du X; Wei Y; Mojsov S; Chow BK
FEBS Lett; 1999 Sep; 457(3):499-504. PubMed ID: 10471837
[TBL] [Abstract][Full Text] [Related]
43. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
[TBL] [Abstract][Full Text] [Related]
44. Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase.
Satoh F; Beak SA; Small CJ; Falzon M; Ghatei MA; Bloom SR; Smith DM
Endocrinology; 2000 Apr; 141(4):1301-9. PubMed ID: 10746632
[TBL] [Abstract][Full Text] [Related]
45. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor.
Gremlich S; Porret A; Hani EH; Cherif D; Vionnet N; Froguel P; Thorens B
Diabetes; 1995 Oct; 44(10):1202-8. PubMed ID: 7556958
[TBL] [Abstract][Full Text] [Related]
46. The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.
Al-Sabah S; Al-Fulaij M; Shaaban G; Ahmed HA; Mann RJ; Donnelly D; Bünemann M; Krasel C
PLoS One; 2014; 9(9):e106890. PubMed ID: 25191754
[TBL] [Abstract][Full Text] [Related]
47. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.
Yang H; Egan JM; Wang Y; Moyes CD; Roth J; Montrose MH; Montrose-Rafizadeh C
Am J Physiol; 1998 Sep; 275(3):C675-83. PubMed ID: 9730951
[TBL] [Abstract][Full Text] [Related]
48. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.
Ehses JA; Lee SS; Pederson RA; McIntosh CH
J Biol Chem; 2001 Jun; 276(26):23667-73. PubMed ID: 11323439
[TBL] [Abstract][Full Text] [Related]
49. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
[TBL] [Abstract][Full Text] [Related]
50. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
[TBL] [Abstract][Full Text] [Related]
51. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells.
Almind K; Ambye L; Urhammer SA; Hansen T; Echwald SM; Holst JJ; Gromada J; Thorens B; Pedersen O
Diabetologia; 1998 Oct; 41(10):1194-8. PubMed ID: 9794107
[TBL] [Abstract][Full Text] [Related]
52. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.
Baggio LL; Kim JG; Drucker DJ
Diabetes; 2004 Dec; 53 Suppl 3():S205-14. PubMed ID: 15561912
[TBL] [Abstract][Full Text] [Related]
53. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
Yuliantie E; Darbalaei S; Dai A; Zhao P; Yang D; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2020 Jul; 177():114001. PubMed ID: 32360365
[TBL] [Abstract][Full Text] [Related]
54. Glucose-dependent insulinotropic polypeptide stimulated insulin release from a tumor-derived beta-cell line (beta TC3).
Kieffer TJ; Verchere CB; Fell CD; Huang Z; Brown JC; Pedersen RA
Can J Physiol Pharmacol; 1993 Dec; 71(12):917-22. PubMed ID: 7910109
[TBL] [Abstract][Full Text] [Related]
55. GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.
Deacon CF; Plamboeck A; Rosenkilde MM; de Heer J; Holst JJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E468-75. PubMed ID: 16608883
[TBL] [Abstract][Full Text] [Related]
56. Two cytoplasmic loops of the glucagon receptor are required to elevate cAMP or intracellular calcium.
Cypess AM; Unson CG; Wu CR; Sakmar TP
J Biol Chem; 1999 Jul; 274(27):19455-64. PubMed ID: 10383462
[TBL] [Abstract][Full Text] [Related]
57. Selectivity of peptide ligands for the human incretin receptors expressed in HEK-293 cells.
Al-Sabah S; Al-Fulaij M; Ahmed HA
Eur J Pharmacol; 2014 Oct; 741():311-5. PubMed ID: 25179575
[TBL] [Abstract][Full Text] [Related]
58. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
Bhat VK; Kerr BD; Flatt PR; Gault VA
Biochem Pharmacol; 2013 Jun; 85(11):1655-62. PubMed ID: 23518155
[TBL] [Abstract][Full Text] [Related]
59. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
60. GIP(3-30)NH
Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
